These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 15565569

  • 1. Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial.
    Färkkilä M, Karvonen AL, Nurmi H, Nuutinen H, Taavitsainen M, Pikkarainen P, Kärkkäinen P.
    Hepatology; 2004 Dec; 40(6):1379-86. PubMed ID: 15565569
    [Abstract] [Full Text] [Related]

  • 2. High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study.
    Olsson R, Boberg KM, de Muckadell OS, Lindgren S, Hultcrantz R, Folvik G, Bell H, Gangsøy-Kristiansen M, Matre J, Rydning A, Wikman O, Danielsson A, Sandberg-Gertzén H, Ung KA, Eriksson A, Lööf L, Prytz H, Marschall HU, Broomé U.
    Gastroenterology; 2005 Nov; 129(5):1464-72. PubMed ID: 16285948
    [Abstract] [Full Text] [Related]

  • 3. High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective.
    Cullen SN, Rust C, Fleming K, Edwards C, Beuers U, Chapman RW.
    J Hepatol; 2008 May; 48(5):792-800. PubMed ID: 18314215
    [Abstract] [Full Text] [Related]

  • 4. High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis.
    Harnois DM, Angulo P, Jorgensen RA, Larusso NF, Lindor KD.
    Am J Gastroenterol; 2001 May; 96(5):1558-62. PubMed ID: 11374699
    [Abstract] [Full Text] [Related]

  • 5. Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group.
    van Hoogstraten HJ, Vleggaar FP, Boland GJ, van Steenbergen W, Griffioen P, Hop WC, van Hattum J, van Berge Henegouwen GP, Schalm SW, van Buuren HR.
    Am J Gastroenterol; 2000 Aug; 95(8):2015-22. PubMed ID: 10950051
    [Abstract] [Full Text] [Related]

  • 6. [Primary sclerosing cholangitis: conventional and quantitative liver function tests during long-term therapy with ursodeoxycholic acid].
    Schönfeld J, Zotz R, Mahl M, Beste M, Breuer N, Goebell H.
    Z Gastroenterol; 1996 Feb; 34(2):123-7. PubMed ID: 8659187
    [Abstract] [Full Text] [Related]

  • 7. Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis.
    Triantos CK, Koukias NM, Nikolopoulou VN, Burroughs AK.
    Aliment Pharmacol Ther; 2011 Oct; 34(8):901-10. PubMed ID: 21883323
    [Abstract] [Full Text] [Related]

  • 8. Association between reduced levels of alkaline phosphatase and survival times of patients with primary sclerosing cholangitis.
    Lindström L, Hultcrantz R, Boberg KM, Friis-Liby I, Bergquist A.
    Clin Gastroenterol Hepatol; 2013 Jul; 11(7):841-6. PubMed ID: 23353641
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ursodeoxycholic acid and methotrexate for primary sclerosing cholangitis: a pilot study.
    Lindor KD, Jorgensen RA, Anderson ML, Gores GJ, Hofmann AF, LaRusso NF.
    Am J Gastroenterol; 1996 Mar; 91(3):511-5. PubMed ID: 8633500
    [Abstract] [Full Text] [Related]

  • 14. Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis.
    Wunsch E, Trottier J, Milkiewicz M, Raszeja-Wyszomirska J, Hirschfield GM, Barbier O, Milkiewicz P.
    Hepatology; 2014 Sep; 60(3):931-40. PubMed ID: 24519384
    [Abstract] [Full Text] [Related]

  • 15. Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials.
    Shi J, Wu C, Lin Y, Chen YX, Zhu L, Xie WF.
    Am J Gastroenterol; 2006 Jul; 101(7):1529-38. PubMed ID: 16863557
    [Abstract] [Full Text] [Related]

  • 16. Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis.
    Heathcote EJ, Stone J, Cauch-Dudek K, Poupon R, Chazouilleres O, Lindor KD, Petz J, Dickson ER, Poupon RE.
    Liver Transpl Surg; 1999 Jul; 5(4):269-74. PubMed ID: 10388499
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.